These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6409001)

  • 1. [Conversion of 1-(2-tetrahydrofuryl-5-fluorouracil (FT-207) into 5-fluorouracil (5-FU) by human maxillary cancer cells (OKK) in culture].
    Yoneda T; Ogawa T; Sakuda M
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1207-8. PubMed ID: 6409001
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metabolism of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) in human maxillary cancer (OKK) cells in culture].
    Yoneda T; Ogawa T; Sakuda M
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1306-11. PubMed ID: 3923943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [N1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) is metabolized and converted to 5-fluorouracil in tumor cells].
    Nio Y; Imai S; Ohgaki K; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1987 Apr; 22(3):582-9. PubMed ID: 3116129
    [No Abstract]   [Full Text] [Related]  

  • 4. Continuous intravenous administration of 1-(2-tetrahydrofuryl)-5-fluorouracil [FT] by intravenous hyperalimentation (IVH)--stability of FT in IVH solution and tumor levels of 5-fluorouracil (5-FU).
    Moriya Y; Koyama Y; Hojo K; Tsunematsu R
    Jpn J Clin Oncol; 1983 Mar; 13(1):31-5. PubMed ID: 6403740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enzymatic conversion of tegafur in human tumor tissue].
    Hara Y; Sugata S; Kono A; Tanaka M
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1511-7. PubMed ID: 6409007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxylated metabolies of R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (Ftorafur) in rats and rabbits.
    Wu AT; Au JL; Sadée W
    Cancer Res; 1978 Jan; 38(1):210-4. PubMed ID: 338145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [FT-207 and 5-FU concentrations in brain tumor tissues, plasma and CSF after administration of FT-207 suppository].
    Matsuura H; Nakazawa S
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):912-6. PubMed ID: 6426399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of chemotherapy of breast cancer (2). Clinical evaluation of the blood and tissue concentrations of FT-207 following intrarectal administration].
    Hiraide H; Mimura K; Kawano M; Hatsuse K; Kadota T; Kurokawa T; Tamaki K; Kanabe S; Mizoguchi O; Terashima H; Iwasa H
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):992-6. PubMed ID: 6408994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the concentration of FT-207 and 5-FU in serum, lymph nodes and tissues after administration of FT-207 suppositories].
    Kumazawa H; Imai N; Shioya M; Kato K; Fukaya Y; Noguchi A
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1655-62. PubMed ID: 6433799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of 1-(2-tetrahydrofuryl)-5-fluorouracil to 5-fluorouracil in partially hepatectomized rats.
    Maehara Y; Takahashi I; Yoshida M; Emi Y; Baba H; Kusumoto H; Kohnoe S; Sugimachi K
    Anticancer Drugs; 1992 Apr; 3(2):117-20. PubMed ID: 1525388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative studies on the metabolism of 2-(tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil.
    Toide H; Akiyoshi H; Minato Y; Okuda H; Fujii S
    Gan; 1977 Oct; 68(5):553-60. PubMed ID: 22472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study of serum and tissue concentrations of FT-207 and 5-FU in patients with cancer of the large intestine following preoperative application of FT-207 suppositories].
    Okuda M; Teramoto T; Yoshida H; Sato K; Ushijima Y; Uematsu Y
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1580-8. PubMed ID: 6820920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Postoperative adjuvant chemotherapy with N1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) for gastric cancer patients. Influence of fat emulsification on lymphatic transport].
    Hanaue H; Kurosawa T; Kitano Y; Miyakawa S; Horie F; Nemoto A; Shikata J
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1515-20. PubMed ID: 6440936
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thermotherapy for cancer of the urinary bladder in combination with tegafur and picibanil--with special reference to the serum bladder and bladder cancer tissue concentrations of tegafur in a perfusion fluid].
    Murahashi I; Kanbe K; Kaneko K; Honda M; Maeda S; Takahashi E
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1781-8. PubMed ID: 6433803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison between FT-207 and 5-FU on intravesical absorption--experimental study on intravesical absorption in the dog].
    Nakagawa S; Kobayashi T; Nakao M; Toyoda K; Mishina T; Miyakoda K
    Hinyokika Kiyo; 1985 Jul; 31(7):1227-31. PubMed ID: 3933286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [UFT concentration in various tissues from cancer patients].
    Kasai Y; Nakanishi Y; Nishi H; Nishindai H; Yoshimoto M; Nakamura T; Hashimoto I; Sawada Y; Mikami J; Bekki E
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2130-8. PubMed ID: 6414381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the correlation between tissue uptake of anticancer agents and prognosis -- with special reference to Tegafur].
    Arima S; Futami K; Kinashi M; Shigeta M; Jyozaki H; Shimura H
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1788-95. PubMed ID: 6411003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General pharmacological properties of UFT, a new type of anti-cancer agent consisting of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT) and uracil. I: Pharmacological analysis of the combined effect of FT and uracil.
    Yamamoto J; Toide K; Haruno A; Yoshimura Y; Unemi N
    Arzneimittelforschung; 1981; 31(8):1268-78. PubMed ID: 6794578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of uracil on the both reactions, 5-fluorouracil degradation into 2-fluoro-beta-alanine and 5-fluorouracil splitting from tegafur in human tumor].
    Kono A; Hara Y; Furusawa M
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2663-5. PubMed ID: 2505686
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacokinetics of fluoropyrimidines].
    Fujita H
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2307-15. PubMed ID: 6437341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.